Latest / The Series A Show with Fexingo: Early-Stage Funding, Pitch Decks, and Startup Milestones / Why the Tesla Rout Is Rewriting Series A Term Sheets
Transcript
- Lucas: So Tesla down nearly 19 percent in the last five trading days. That's not just a problem for Tesla shareholders — it's rippling through the startup funding ecosystem in a way that founders and Series A investors are only starting to talk about. Luna: Wait, how does a big public stock drop affect early-stage fundraising? Seems like two different worlds. Lucas: You'd think so, but look at who's writing Series A checks. A ton of crossover funds — firms like Tiger Global, Coatue, and even some family offices — have huge public-equity holdings, and Tesla is a core position for many of them. When those stocks tank, their overall portfolio takes a hit, and they get more conservative with new commitments. Luna: Right, so a fund that was planning to lead a five-million-dollar Series A might suddenly pull back or demand tougher terms because their NAV just dropped. Lucas: Exactly. And it's not just Tesla. ARKK — Cathie Wood's flagship ETF — is down 7 percent over the same period. META lost 7.5 percent. So any investor heavy on growth tech is feeling the pinch. I've been hearing from founders who are now explicitly asking lead investors how concentrated their public holdings are before signing a term sheet. Luna: That's almost like a reverse due diligence. So what are they doing about it structurally? Lucas: Some startups are starting to add syndicate diversification clauses. For example, I spoke with a founder closing a twelve million dollar Series A who insisted that no single investor could take more than 25 percent of the round. That way, if one backer's public portfolio drops, they can't hold the entire round hostage. Luna: Twenty-five percent is pretty standard from a control perspective, but the motivation there is different — it's about mitigating concentration risk from market volatility. Lucas: Right. And the more interesting innovation is what I'd call a 'key investor stock drop trigger.' This is a clause some founders are putting in term sheets that says if the lead investor's public portfolio — or a designated benchmark — drops by more than, say, 15 percent between signing and closing, the valuation cap or discount gets renegotiated. Luna: Wow. That's a huge shift. Traditionally, term sheets are locked once signed, but this gives the startup an escape hatch if the capital source gets shaky. Lucas: Yeah, and it's contentious. I've heard of a few VCs pushing back hard, saying it introduces too much uncertainty. But founders are pointing to the past week and saying, 'Look, your own portfolio just lost nearly a fifth of its value. Why should my valuation be based on your pre-crash balance sheet?' Luna: Fair point. But how enforceable is that in practice? I mean, the investor could just say no and walk. Lucas: That's the risk. And we're in a market where there's still plenty of capital chasing deals, but the tone has definitely shifted. Founders I talk to say they're getting more questions about their own burn multiples and path to profitability, which used to be more of a Series B conversation. Luna: So the volatility is trickling down to basic valuation discipline. That actually might be healthy for the ecosystem in the long run. Lucas: I think so. But the immediate impact is that founders need to be savvier about who they let into their cap table. It's not just about money anymore — it's about the stability of that money. And whether the investor's own house is in order. Luna: Speaking of which, if this kind of insight helps you think about your own fundraising strategy — whether you're a founder or an investor — it's exactly the kind of conversation we try to have on this show. If today's episode felt worth a coffee to you, you can find the link to support us at buy me a coffee dot com slash fexingo. Lucas: Yeah, listener support keeps us ad-free and focused on the stuff that matters. And it costs less than a latte. So if you're finding value, that's the link. Luna: Alright, back to term sheets. Lucas, you mentioned a specific startup with a diversification clause — can you tell us more about how that actually played out? Lucas: Sure. So the company — it's a B2B SaaS platform in the supply-chain space — they were raising twelve million at around a forty-million valuation. Early on, one crossover fund wanted to take the entire round. The founder said no, and they capped it at three million. The fund wasn't thrilled, but they ended up coming in as a participant. Two weeks later, the fund's public holdings dropped 12 percent in a week. The founder told me he felt vindicated — his round wasn't at risk. Luna: That's a really smart move. But does that require the startup to have enough demand to be picky? If you only have one term sheet, you probably can't impose those conditions. Lucas: Absolutely. It's a privilege of leverage. But the broader point is that even less hot startups can benefit from asking the right questions during due diligence. Ask the lead: 'What's your portfolio correlation to the NASDAQ? How much of your AUM is in illiquid private vs. public?' That at least gives you a sense of their risk profile. Luna: So you're saying founders should treat investor financial health as part of their own risk assessment. Lucas: Exactly. And it's becoming more common. I've seen a few seed-stage VCs start to offer what they call 'syndicate stability reports' — basically a self-disclosure of their own concentration. One firm I know of actually publishes a rolling 30-day liquidity projection so that portfolio companies can see if the VC has cash to participate in future rounds. Luna: That's radical transparency. I wonder if that will become a standard part of the Series A process. Lucas: I think so. We're moving toward a world where the investor-background check is as important as the product due diligence. And it's being accelerated by weeks like this one — where a single stock can wipe out a fund's willingness to deploy capital. Luna: To be fair, Tesla's 19 percent drop is extreme, but it's not the only one. Rivian down 6.6 percent, Coinbase down 5.2 percent, ARKW down 5.7 percent — the broader growth cohort is getting hammered. Lucas: Right. And it's not just the direct holdings — it's the second-order effects. When a fund's publicly traded positions drop, their overall NAV falls, which can trigger limited-partner covenants. Some LPs have clauses that require the GP to reduce risk, which means less new investments. That's how a Tesla rout ends up drying up Series A capital for a robotics startup in Pittsburgh. Luna: So founders need to be aware of that chain reaction. If you're raising in the next few months, you might want to build a buffer — maybe raise a bit more than you need, or bring in a few smaller investors to spread the risk. Lucas: Exactly. And the term sheet innovations we're seeing — diversification caps, stock drop triggers, syndicate health disclosures — they're all reactions to this new reality. I wouldn't be surprised if by early next year, these become boilerplate in most Series A term sheets. Luna: That seems like a positive evolution. More transparency, more stability. Although I'm sure some VCs will fight it. Lucas: They will. But the market is sending a clear signal: the days of writing a check from a concentrated portfolio with no accountability are numbered. Founders are getting smarter, and this week's data gives them the ammunition to ask tough questions. Luna: Alright, well, for anyone raising their Series A right now, pay attention to who's in your syndicate. And if you want to keep hearing insights like this, you know how to support us. Lucas: Yeah. Thanks for listening, and we'll catch you next time.